This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1u6q
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1u6q" size="450" color="white" frame="true" align="right" spinBox="true" caption="1u6q, resolution 2.02Å" /> '''Substituted 2-Napht...)
Next diff →
Revision as of 17:25, 12 November 2007
|
Substituted 2-Naphthamadine inhibitors of Urokinase
Contents |
Overview
A series of non-amide-linked 6-substituted-2-naphthamidine urokinase, plasminogen activator (uPA) inhibitors are described. These compounds, possess excellent binding activities and selectivities with significantly, improved pharmacokinetic profiles versus previously described amide-linked, inhibitors.
Disease
Known disease associated with this structure: Alzheimer disease, late-onset, susceptibility to OMIM:[191840]
About this Structure
1U6Q is a Single protein structure of sequence from Homo sapiens with 745 as ligand. Active as U-plasminogen activator, with EC number 3.4.21.73 Full crystallographic information is available from OCA.
Reference
Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties., Bruncko M, McClellan WJ, Wendt MD, Sauer DR, Geyer A, Dalton CR, Kaminski MA, Weitzberg M, Gong J, Dellaria JF, Mantei R, Zhao X, Nienaber VL, Stewart K, Klinghofer V, Bouska J, Rockway TW, Giranda VL, Bioorg Med Chem Lett. 2005 Jan 3;15(1):93-8. PMID:15582418
Page seeded by OCA on Mon Nov 12 19:32:12 2007
